Article Information
History
- October 15, 2019.
Article Versions
- Version 1 (June 21, 2019 - 12:16).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Eline M. Krijkamp*,1,
- Fernando Alarid-Escudero*,†,2,
- Eva A. Enns3,
- Petros Pechlivanoglou4,5,
- M.G. Myriam Hunink6,7 and
- Hawre J. Jalal8
- 1Department of Epidemiology, Erasmus University Medical Center Rotterdam, The Netherlands
- 2Drug Policy Program, Center for Research and Teaching in Economics, (CIDE)-CONACyT Aguascalientes, Ags., Mexico, 20313
- 3Division of Health Policy and Management, University of Minnesota School of Public Health Minneapolis, MN, USA 55455
- 4Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON, Canada
- 5Institute for Health Policy Management and Evaluation, University of Toronto, ON, Canada
- 6Departments of Epidemiology and Radiology, Erasmus University Medical Center Rotterdam, The Netherlands
- 7Center of Health Decision Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 8Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA
- ↵†Corresponding author, fernando.alarid{at}cide.edu
↵* Contributed equally to this work.